Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if NVCT is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
17 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 7
83 filers reported a long position in NVCT for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $28.5M | 1.6M | New |
| BlackRock, Inc. | $18.4M | 1M | +31% |
| PERCEPTIVE ADVISORS LLC | $18.4M | 1M | New |
| Soleus Capital Management, L.P. | $18.4M | 1M | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $16M | 872.5K | +32.2% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $14.3M | 777.1K | +19.2% |
| GEODE CAPITAL MANAGEMENT, LLC | $8M | 432.3K | +12.5% |
| Occam Crest Management LP | $7.4M | 357.1K | -12.3% |
| SPHERA FUNDS MANAGEMENT LTD. | $7M | 382.9K | New |
| BALDWIN WEALTH PARTNERS LLC/MA | $7M | 382K | +0.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.